secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2026-06-17T20:49:40+00:00
Accession:  0002077096-26-000203
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED appoints John E. Gallagher as CFO effective July 15, 2026
----------------------------------------------------------------

- Gallagher joins from Certara (CFO); previously CFO at Cue Health and SVP/CFO at BD Medical Segment.
- Base salary $650,000; target bonus 85%; equity grants valued at $2.3M plus $1.5M make-up RSUs.
- Outgoing CFO Todd Garner stays in advisory capacity through November 2, 2026.
- President/CEO Patrick Beyer and Kimberly Lockwood cease interim CFO/accounting roles on effective date.
- Gallagher eligible for severance under CONMED Executive Severance Plan (1.5x base + average bonus).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000207709626000203/0002077096-26-000203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000207709626000203/ea0295016-8k_conmed.htm
  HTML page:      https://secwatch.observer/filing/0002077096-26-000203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer